Activation of poly-ADP-ribose polymerase 1 (PARP1) in response to hyperglycemia will cause the inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity due to depletion of glycolytic intermediates and resulting in an accumulation of upstream metabolites. This evidence concerns the gene PARP1 and Hyperglycemia.